logo

NMR

Nomura Holdings·NYSE
--
--(--)
--
--(--)
5.96 / 10
Netural

Nomura's fundamental analysis yields a balanced rating of 6.0/10. Key positives include robust asset and revenue metrics (Asset-MV and Revenue-MV both scoring 2/3), high fixed-asset turnover (3/3), and impressive YoY EPS growth (3/3 for both basic and diluted). However, challenges persist in return metrics (Rate of return on total assets at 1/3) and dividend safety (F rating, indicating a history of cuts in 64.4% of similar cases over 11 years). Overall, the fundamentals are solid but not outstanding, warranting a neutral stance.

Fundamental(5.96)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value0.61
Score2/3
Weight8.97%
1M Return2.45%
Current liabilities / Total liabilities (%)
Value53.71
Score2/3
Weight5.45%
1M Return1.79%
Net income-Revenue
Value0.48
Score3/3
Weight17.71%
1M Return4.61%
Basic earnings per share (YoY growth rate %)
Value109.75
Score3/3
Weight15.52%
1M Return4.28%
Rate of return on total assets (%)
Value-7.69
Score1/3
Weight4.48%
1M Return1.42%
Fixed assets turnover ratio
Value28052.73
Score3/3
Weight8.91%
1M Return2.65%
Annualized return on total assets (%)
Value-7.69
Score1/3
Weight4.48%
1M Return1.42%
Diluted earnings per share (YoY growth rate %)
Value110.72
Score3/3
Weight18.06%
1M Return4.99%
Asset-MV
Value3.24
Score2/3
Weight9.15%
1M Return2.74%
Current assets / Total assets (%)
Value42.04
Score3/3
Weight7.27%
1M Return2.31%
Is NMR undervalued or overvalued?
  • NMR scores 5.96/10 on fundamentals and holds a Fair valuation at present. Backed by its 7.79% ROE, 18.20% net margin, 11.13 P/E ratio, 1.10 P/B ratio, and 18.84% earnings growth, these metrics solidify its Netural investment rating.